ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,608Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 469

$340K Total Retail Price of All Prescriptions

Rank: 28 out of 469

232 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 5,829 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 602 334 1 4
LISINOPRIL 397 285 2 2
SIMVASTATIN 395 265 3 1
OMEPRAZOLE 384 296 4 3
FUROSEMIDE 308 248 5 7
POTASSIUM CHLORIDE 258 239 6 19
METOPROLOL TARTRATE 244 198 7 9
AMLODIPINE BESYLATE 213 152 8 5
RANITIDINE HCL 212 98 9 28
METFORMIN HCL 208 75 10 6
ATORVASTATIN CALCIUM 189 102 11 23
SERTRALINE HCL 156 138 12 26
DONEPEZIL HCL 152 130 13 39
QUETIAPINE FUMARATE 144 116 14 66
CRESTOR 117 43 15 20
CELEBREX 105 76 16 99
RISPERIDONE 102 83 17 43
ENALAPRIL MALEATE 98 74 18 36
POLYETHYLENE GLYCOL 3350 95 82 19 131
CITALOPRAM HBR 91 68 20 22
HYDROCHLOROTHIAZIDE 91 60 20 8
AMITRIPTYLINE HCL 90 56 R 22 63
TRAZODONE HCL 88 71 23 34
HYDROXYZINE HCL 87 47 R 24 189
DIGOXIN 87 85 24 107
GLYBURIDE 83 59 R 26 53
TRAMADOL HCL 81 42 27 11
GLIPIZIDE 79 52 28 13
PAROXETINE HCL 77 50 29 116
IBUPROFEN 76 47 30 49
METOPROLOL SUCCINATE 75 73 31 30
DIOVAN 73 36 32 81
GABAPENTIN 73 57 32 12
ATENOLOL 71 42 34 17
MELOXICAM 69 42 35 15
NAMENDA 67 56 36 56
MIRTAZAPINE 59 45 37 103
BUSPIRONE HCL 58 50 38 101
BUPROPION XL 58 40 38 123
CLONIDINE HCL 57 24 40 58
OXYBUTYNIN CHLORIDE 56 25 41 111
BENZTROPINE MESYLATE 54 36 R 42 70
CLOPIDOGREL 53 53 43 47
FAMOTIDINE 51 38 44 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.